Rinaldi, Ciro R., Rinaldi, Paola, Alagia, Adele , Gemei, Marica, Esposito, Nicola, Formiggini, Fabio, Martinelli, Vincenzo, Senyuk, Vitalyi, Nucifora, Giuseppina and Pane, Fabrizio (2010) Preferential nuclear accumulation of JAK2V617F in CD34+ but not in granulocytic, megakaryocytic, or erythroid cells of patients with Philadelphia-negative myeloproliferative neoplasia. Blood, 116 (26). pp. 6023-6026. ISSN 0006-4971
Full content URL: http://dx.doi.org/10.1182/blood-2010-08-302265
Others |
|
![]() |
Other (PDF)
6023.long - Whole Document Restricted to Repository staff only 120kB |
Item Type: | Article |
---|---|
Item Status: | Live Archive |
Abstract
Recently, Dawson et al identified a previously unrecognized nuclear role of JAK2 in the phosphorylation of histone H3 in hematopoietic cell lines. We searched nuclear JAK2 in total bone marrow (BM) cells and in 4 sorted BM cell populations (CD34(+), CD15(+), CD41(+), and CD71(+)) of 10 myeloproliferative neoplasia (MPN) patients with JAK2V617F mutation and 5 patients with wild-type JAK2 MPN. Confocal immunofluorescent images and Western blot analyses of nuclear and cytoplasmic fractions found nuclear JAK2 in CD34(+) cells of 10 of 10 JAK2-mutated patients but not in patients with wild-type JAK2. JAK2 was predominantly in the cytoplasmic fraction of differentiated granulocytic, megakaryocytic, or erythroid cells obtained from all patients. JAK2V617F up-regulates LMO2 in K562 and in JAK2V617F-positive CD34(+) cells. The selective JAK2 inhibitor AG490 normalizes the LMO2 levels in V617F-positive K562 and restores the cyto-plasmic localization of JAK2.
Additional Information: | published ahead of print September 22, 2010 |
---|---|
Keywords: | jak2, MPN |
Subjects: | A Medicine and Dentistry > A100 Pre-clinical Medicine |
Divisions: | College of Science > School of Life Sciences |
ID Code: | 12412 |
Deposited On: | 24 Oct 2013 16:25 |
Repository Staff Only: item control page